Related Experiment Videos
Oxidative signalling and inflammatory pathways in Alzheimer's disease
I Anderson1, C Adinolfi, S Doctrow
1Cambridge Antibody Technology Ltd., Science Park, Melbourn SG8 6JJ, U.K.
Biochemical Society Symposium
|July 13, 2001
Summary
Inflammation and oxidative stress are central to Alzheimer's disease (AD) pathology. Novel manganese complexes show potential in protecting against AD-related cellular damage by targeting these processes.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Inflammation and oxidative stress are recognized as critical factors in Alzheimer's disease (AD) pathogenesis.
- The precise early molecular mechanisms and mediators involved in AD's pathological cascade remain incompletely understood.
Purpose of the Study:
- To investigate the molecular underpinnings of inflammation and oxidative stress in microglial activation and neuronal cell viability.
- To evaluate the therapeutic potential of novel manganese-salen complexes against AD-related cellular damage.
Main Methods:
- Utilized beta-amyloid peptide (A beta 42) to activate microglial cells.
- Assessed the production of inflammatory mediators like cyclooxygenase-2, inducible nitric oxide synthase, and tumor necrosis factor-alpha.
- Examined the protective effects of manganese-salen complexes (EUK-8, -134, -189) against hydrogen peroxide and peroxynitrite-induced cellular insults.
Main Results:
- A beta 42 activation of microglia induced cyclooxygenase-2, inducible nitric oxide synthase, and tumor necrosis factor-alpha.
- Manganese-salen complexes, particularly EUK-134, demonstrated protective effects against oxidative stress.
- EUK-134 also inhibited prostaglandin E2 production in activated microglial cells.
Conclusions:
- Oxidative stress and inflammation play pivotal roles in the Alzheimer's disease pathological cascade.
- Manganese-salen complexes represent promising therapeutic candidates for targeting these pathways in AD.